Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting

Open access
Straka, Robert J, Liu, Larry Z, Girase, Prafulla S, DeLorenzo, Allyson, Chapman, Richard H · 2009 · Cardiovascular Diabetology

Abstract

BACKGROUND: Patients with type 2 diabetes are at increased risk of cardiovascular events, and there is an associated economic burden attached to this risk. We conducted a retrospective claims database analysis to evaluate incremental cardiovascular costs in diabetic versus non-diabetic patients hospitalized for a cardiovascular event. METHODS: Patients hospitalized for a cardiovascular event between January 1, 2001 and June 30, 2005 were identified from a large US managed-care population. Diabetic patients were identified by evidence of type 2 diabetes in the 12 months prior to the index hospitalization. Direct medical costs and resource use - including inpatient expenditures (for the index and first recurrent hospitalizations), as well as outpatient, laboratory, and pharmacy expenditures (during the 3-year follow-up period) - were determined for patients with or without diabetes. RESULTS: Of the 29,863 patients identified with a cardiovascular hospitalization, 5,501 patients (18.4%) had a history of diabetes in the pre-index period (mean age, 57.8 years; 42.1% female). The overall mean follow-up period was 22.8 months. The incidence of subsequent cardiovascular events in the first year of follow-up was significantly higher for patients with diabetes compared with non-diabetic patients for all types of cardiovascular events except angina. Compared with non-diabetic patients, patients with diabetes had similar mean direct medical costs per patient for the index cardiovascular hospitalization ($17,435 versus $16,917; P = 0.09), and the first recurrent cardiovascular hospitalization ($18,488 versus $17,481; P = 0.2), yet higher mean total direct medical costs per patient for cardiovascular events during follow-up years (Year 1: $8,805 versus $6,982; Year 2: $13,860 versus $10,056; Year 3: $16,149 versus $12,163; all P < or = 0.0002). The cost difference between diabetic and non-diabetic patients remained significant after adjusting for age, gender and other potential confounders in multivariate regression analysis. The mean (SD) total period of inpatient cardiovascular hospitalization after 3 years of follow-up was 3.3 (12.4) days for patients with diabetes compared with 1.8 (5.8) days for non-diabetic patients (P < 0.0001). CONCLUSION: Diabetic patients hospitalized for a cardiovascular event incur higher costs for cardiovascular care than their non-diabetic counterparts. This analysis of the incremental cardiovascular cost and resource use provides the basis for greater accuracy and precision when modeling the economic value of initiatives aimed at reducing cardiovascular morbidity in patients with diabetes mellitus.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1475-2840-8-53

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The study cohort identification procedure with the final study cohort stratified by history of type 2 diabetes in the 12 months prior to hospitalization. CV, cardiovascular. Figure provides an overview of the patient identification procedure with reasons for inclusion/exclusion through the selection process.
Figure 1 The study cohort identification procedure with the final study cohort stratified by history of type 2 diabetes in the 12 months prior to hospitalization. CV, cardiovascular. Figure provides an overview of the patient identification procedure with reasons for inclusion/exclusion through the selection process.CC BY · PubMed Central
Figure 2 Total mean direct medical costs per patient over 3 years of follow up for all cardiovascular events (left-hand graph) and for selected cardiovascular event types (right-hand graph). CABG, coronary artery bypass graft; CV, cardiovascular; DM, diabetes mellitus; MI, myocardial infarction. Data provided represent the mean total cumulative direct medical costs per patient for cardiovascular events across 3 years of follow-up for all cardiovascular events and for selected event types.
Figure 2 Total mean direct medical costs per patient over 3 years of follow up for all cardiovascular events (left-hand graph) and for selected cardiovascular event types (right-hand graph). CABG, coronary artery bypass graft; CV, cardiovascular; DM, diabetes mellitus; MI, myocardial infarction. Data provided represent the mean total cumulative direct medical costs per patient for cardiovascular events across 3 years of follow-up for all cardiovascular events and for selected event types.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 67

Metadata

Authors
Straka, R. J., Liu, L. Z., Girase, P. S., DeLorenzo, A., & Chapman, R. H.
Affiliations
  • University of Minnesota (US)
  • Pfizer (United States) (US)
  • Columbia University (US)
  • IQVIA (United States) (US)
Corresponding author
Straka, Robert J
Venue
Cardiovascular Diabetology
Published
2009
Volume
8
Issue
1
Pages
53
ISSN
1475-2840 (ISSN-L)
OpenAlex
W2060220120
Cited by
67
References
25
Citations by year
2026: 1 · 2025: 3 · 2024: 15 · 2023: 7 · 2022: 4 · 2021: 1 · 2020: 2 · 2018: 5 · 2017: 5 · 2016: 5 · 2015: 9 · 2014: 2 · 2013: 2 · 2012: 2
FWCI
1.46
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Cardiovascular Diabetology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Pfizer
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords
type 2 diabetes, cardiovascular events, cardiovascular hospitalization, health care costs, resource utilization (health care), recurrent hospitalization, economic burden of diabetes, managed care, length of hospital stay, cardiovascular risk in diabetes, angina pectoris, myocardial infarction, stroke, congestive heart failure, heart failure readmission
MeSH terms
Adult, Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Health Resources, Humans, Male, Managed Care Programs, Middle Aged, Retrospective Studies, United States, Cohort Studies, Health Care Costs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting. https://app.cochat.ai/papers/10.1186/1475-2840-8-53
The paper
Straka, R. J., Liu, L. Z., Girase, P. S., DeLorenzo, A., & Chapman, R. H. (2009). Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting. Cardiovascular Diabetology. https://doi.org/10.1186/1475-2840-8-53

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.